Walter Hanel
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas (NCT04774068) | Walter Hanel | 2021-09-01 |
Track Walter Hanel automatically
Every clearance here is in the API, with alerts when new ones post.